uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab
Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden..
Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden..
Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden..
Lund Univ, Dept Neurol, Lund, Sweden..
Show others and affiliations
2015 (English)In: Multiple Sclerosis, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 21, 285-286 p.Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2015. Vol. 21, 285-286 p.
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-276950ISI: 000365729400490OAI: oai:DiVA.org:uu-276950DiVA: diva2:905619
Conference
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), OCT 07-10, 2015, Barcelona, SPAIN
Available from: 2016-02-23 Created: 2016-02-16 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Landtblom, Anne-MarieBurman, Joachim

Search in DiVA

By author/editor
Landtblom, Anne-MarieBurman, Joachim
By organisation
NeurologyClinical Immunology
In the same journal
Multiple Sclerosis
Neurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 212 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf